← All trials
NCT04396990
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 15, 2020
- Primary completion
- Oct 1, 2020
- Completion date
- Oct 31, 2020
- First posted
- May 22, 2020
- Last posted
- May 22, 2020
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Vance Thompson VisionLead sponsor
- Ocular Therapeutix, Inc.Collaborator
- Vance Thompson VisionReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.